Literature DB >> 19228967

The cochaperone BAG2 sweeps paired helical filament- insoluble tau from the microtubule.

Daniel C Carrettiero1, Israel Hernandez, Pierre Neveu, Thales Papagiannakopoulos, Kenneth S Kosik.   

Abstract

Tau inclusions are a prominent feature of many neurodegenerative diseases including Alzheimer's disease. Their accumulation in neurons as ubiquitinated filaments suggests a failure in the degradation limb of the Tau pathway. The components of a Tau protein triage system consisting of CHIP/Hsp70 and other chaperones have begun to emerge. However, the site of triage and the master regulatory elements are unknown. Here, we report an elegant mechanism of Tau degradation involving the cochaperone BAG2. The BAG2/Hsp70 complex is tethered to the microtubule and this complex can capture and deliver Tau to the proteasome for ubiquitin-independent degradation. This complex preferentially degrades Sarkosyl insoluble Tau and phosphorylated Tau. BAG2 levels in cells are under the physiological control of the microRNA miR-128a, which can tune paired helical filament Tau levels in neurons. Thus, we propose that ubiquitinated Tau inclusions arise due to shunting of Tau degradation toward a less efficient ubiquitin-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19228967      PMCID: PMC2768429          DOI: 10.1523/JNEUROSCI.4660-08.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  58 in total

1.  In vivo evidence of CHIP up-regulation attenuating tau aggregation.

Authors:  Naruhiko Sahara; Miyuki Murayama; Tatsuya Mizoroki; Makoto Urushitani; Yuzuru Imai; Ryosuke Takahashi; Shigeo Murata; Keiji Tanaka; Akihiko Takashima
Journal:  J Neurochem       Date:  2005-09       Impact factor: 5.372

2.  Combinatorial microRNA target predictions.

Authors:  Azra Krek; Dominic Grün; Matthew N Poy; Rachel Wolf; Lauren Rosenberg; Eric J Epstein; Philip MacMenamin; Isabelle da Piedade; Kristin C Gunsalus; Markus Stoffel; Nikolaus Rajewsky
Journal:  Nat Genet       Date:  2005-04-03       Impact factor: 38.330

3.  Site-specific phosphorylation and caspase cleavage differentially impact tau-microtubule interactions and tau aggregation.

Authors:  Huiping Ding; Tori A Matthews; Gail V W Johnson
Journal:  J Biol Chem       Date:  2006-05-10       Impact factor: 5.157

4.  Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species.

Authors:  Chad A Dickey; Mei Yue; Wen-Lang Lin; Dennis W Dickson; Judith H Dunmore; Wing C Lee; Cynthia Zehr; Gemma West; Songsong Cao; Amber M K Clark; Guy A Caldwell; Kim A Caldwell; Christopher Eckman; Cam Patterson; Michael Hutton; Leonard Petrucelli
Journal:  J Neurosci       Date:  2006-06-28       Impact factor: 6.167

Review 5.  Tau phosphorylation and proteolysis: insights and perspectives.

Authors:  Gail V W Johnson
Journal:  J Alzheimers Dis       Date:  2006       Impact factor: 4.472

6.  DNA damage triggers nucleotide excision repair-dependent monoubiquitylation of histone H2A.

Authors:  Steven Bergink; Florian A Salomons; Deborah Hoogstraten; Tom A M Groothuis; Harm de Waard; Junxin Wu; Li Yuan; Elisabetta Citterio; Adriaan B Houtsmuller; Jacques Neefjes; Jan H J Hoeijmakers; Wim Vermeulen; Nico P Dantuma
Journal:  Genes Dev       Date:  2006-05-15       Impact factor: 11.361

7.  Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation.

Authors:  Diane Cripps; Stefani N Thomas; Young Jeng; Frank Yang; Peter Davies; Austin J Yang
Journal:  J Biol Chem       Date:  2006-01-27       Impact factor: 5.157

8.  CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70.

Authors:  Shu-Bing Qian; Holly McDonough; Frank Boellmann; Douglas M Cyr; Cam Patterson
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

9.  Rapamycin alleviates toxicity of different aggregate-prone proteins.

Authors:  Zdenek Berger; Brinda Ravikumar; Fiona M Menzies; Lourdes Garcia Oroz; Benjamin R Underwood; Menelas N Pangalos; Ina Schmitt; Ullrich Wullner; Bernd O Evert; Cahir J O'Kane; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2005-12-20       Impact factor: 6.150

10.  A dynamic ubiquitin equilibrium couples proteasomal activity to chromatin remodeling.

Authors:  Nico P Dantuma; Tom A M Groothuis; Florian A Salomons; Jacques Neefjes
Journal:  J Cell Biol       Date:  2006-04-10       Impact factor: 10.539

View more
  76 in total

Review 1.  The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases.

Authors:  John R Finnerty; Wang-Xia Wang; Sébastien S Hébert; Bernard R Wilfred; Guogen Mao; Peter T Nelson
Journal:  J Mol Biol       Date:  2010-08-01       Impact factor: 5.469

Review 2.  Heat shock protein 70 (hsp70) as an emerging drug target.

Authors:  Christopher G Evans; Lyra Chang; Jason E Gestwicki
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

Review 3.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

Review 4.  Therapeutic Strategies for Restoring Tau Homeostasis.

Authors:  Zapporah T Young; Sue Ann Mok; Jason E Gestwicki
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

5.  Tumour necrosis factor-α (TNF-α) and miRNA expression in frontal and temporal neocortex in Alzheimer's disease and the effect of TNF-α on miRNA expression in vitro.

Authors:  Doris Culpan; Patrick G Kehoe; Seth Love
Journal:  Int J Mol Epidemiol Genet       Date:  2011-03-25

Review 6.  Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies.

Authors:  Yoshinari Miyata; John Koren; Janine Kiray; Chad A Dickey; Jason E Gestwicki
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

7.  The Co-chaperone BAG2 Mediates Cold-Induced Accumulation of Phosphorylated Tau in SH-SY5Y Cells.

Authors:  Cesar Augusto Dias de Paula; Fernando Enrique Santiago; Adriele Silva Alves de Oliveira; Fernando Augusto Oliveira; Maria Camila Almeida; Daniel Carneiro Carrettiero
Journal:  Cell Mol Neurobiol       Date:  2015-07-25       Impact factor: 5.046

Review 8.  A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.

Authors:  P Hemachandra Reddy; Sahil Tonk; Subodh Kumar; Murali Vijayan; Ramesh Kandimalla; Chandra Sekhar Kuruva; Arubala P Reddy
Journal:  Biochem Biophys Res Commun       Date:  2016-08-12       Impact factor: 3.575

Review 9.  MicroRNA implications across neurodevelopment and neuropathology.

Authors:  Sabata Martino; Ilaria di Girolamo; Antonio Orlacchio; Alessandro Datti; Aldo Orlacchio
Journal:  J Biomed Biotechnol       Date:  2009-10-13

10.  Protein aggregation containing β-amyloid, α-synuclein and hyperphosphorylated τ in cultured cells of hippocampus, substantia nigra and locus coeruleus after rotenone exposure.

Authors:  Rodrigo S Chaves; Thaiany Q Melo; Stephanie A Martins; Merari F R Ferrari
Journal:  BMC Neurosci       Date:  2010-11-10       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.